stent Hyderabad, June 29 of Asia: Catheter of president A.P.J. Abdul Kalam Asia inaugurated per Friday the first and the service of manufacture stent close to Hyderabad and scientists recommended to ind a solution with the problem of the clots of blood caused by a certain drug luant stents.

it required of experts to take research in the stents to compare various types of (drug luant of the stents) and of newer kinds of combinations of drug to be coated on stents to find a solution with the problem of thrombosis.

stent late ” that stent it ideal should be completely inert, not to activate the system of coagulation and should disappear after a given period. Is this possible? You of the experts can make him, “it said to address a meeting of the researchers, possible scientists and the service of the last cry of physicians.

The of Relisys devices that medical Ltd (RMDL) was raised at a cost of Rs.300 million at Manglapally, with approximately 40 kilometers starting from unit of here.

The would make 200.000 stents of all the types every year, including 80.000 those of drug-elutions and 125.000 catheters. It promised to develop various types of the catheters and of stents coronary at the prices appreciably lower than equivalents.

Kalam imported to them indicated than the goal of Relisys should be to launch medical stents, catheters and disposable materials with half of the prices of its competitors all while maintaining quality and the profit margin more raised by higher volumes of sales. “This will imply to increase forces of R & D in the metallurgy, the delivery of drug and the evaluation by creating linkages with the educational establishments and the national laboratories of R & D,” it said.

Kalam additional: “Especially, it is essential to bring confidence among the Indian patients that the stents built by the RMDL are comparable with the stents however been essential that its cost is much lower. The continuous flow of technology on manufacture, the improvement continues entries of design of the cardiologists and the patients are important factors to improve competitiveness on the market. ”

He noted that RMDL explored the possibility of manufacture under contract for the international players. This would increase not only the quality of the products due to the rigorous conditions of quality of the international companies, but would also increase the use of capacity of the factory, additional Kalam.